Chemical Structure : RD162
Catalog No.: PC-35346Not For Human Use, Lab Use Only.
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM; suppresses growth and induces apoptosis in human prostate cancer cells in vitro, demonstrates greater relative affinity than the clinically used antiandrogen bicalutamide, reduces the efficiency of its nuclear translocation, and impairs both DNA binding to androgen response elements and recruitment of coactivators; induces tumor regression in mouse models of castration-resistant human prostate cancer.
M.Wt | 476.45 | |
Formula | C22H16F4N4O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Tran C, et al. Science. 2009 May 8;324(5928):787-90.
2. Makkonen H, et al. Mol Cell Endocrinol. 2011 Jan 1;331(1):57-65.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright